Acorah Software Products - Accounts Production 15.0.600 false true 31 October 2022 1 November 2021 false 1 November 2022 31 October 2023 31 October 2023 08725656 Mr C Dott Christopher Dott false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08725656 2022-10-31 08725656 2023-10-31 08725656 2022-11-01 2023-10-31 08725656 frs-core:ComputerEquipment 2022-11-01 2023-10-31 08725656 frs-core:ShareCapital 2023-10-31 08725656 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31 08725656 frs-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 08725656 frs-bus:AbridgedAccounts 2022-11-01 2023-10-31 08725656 frs-bus:SmallEntities 2022-11-01 2023-10-31 08725656 frs-bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 08725656 frs-bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 08725656 frs-bus:OrdinaryShareClass1 2022-11-01 2023-10-31 08725656 frs-bus:OrdinaryShareClass1 2023-10-31 08725656 1 2022-11-01 2023-10-31 08725656 frs-bus:Director1 2022-11-01 2023-10-31 08725656 frs-countries:EnglandWales 2022-11-01 2023-10-31 08725656 2021-10-31 08725656 2022-10-31 08725656 2021-11-01 2022-10-31 08725656 frs-core:ShareCapital 2022-10-31 08725656 frs-core:RetainedEarningsAccumulatedLosses 2022-10-31 08725656 frs-bus:OrdinaryShareClass1 2021-11-01 2022-10-31
Registered number: 08725656
CSD Pharma Consulting Ltd
ABRIDGED Financial Statements
For The Year Ended 31 October 2023
Bailey Oster
Chartered Accountants
Mellor House
St Petersgate
Stockport
SK1 1DS
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—4
Page 1
Abridged Balance Sheet
Registered number: 08725656
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 252 192
252 192
CURRENT ASSETS
Cash at bank and in hand 17,479 23,646
17,479 23,646
Creditors: Amounts Falling Due Within One Year (2,348 ) (4,721 )
NET CURRENT ASSETS (LIABILITIES) 15,131 18,925
TOTAL ASSETS LESS CURRENT LIABILITIES 15,383 19,117
NET ASSETS 15,383 19,117
CAPITAL AND RESERVES
Called up share capital 5 100 100
Profit and Loss Account 15,283 19,017
SHAREHOLDERS' FUNDS 15,383 19,117
Page 1
Page 2
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 October 2023 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr C Dott
Director
6 August 2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
CSD Pharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08725656 . The registered office is 16 Park Road, Redhill, Surrey, RH1 1BT.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and form the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 33% reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was:
2023 2022
Office and administration 1 1
1 1
Page 3
Page 4
4. Tangible Assets
Total
£
Cost
As at 1 November 2022 1,353
Additions 300
As at 31 October 2023 1,653
Depreciation
As at 1 November 2022 1,161
Provided during the period 240
As at 31 October 2023 1,401
Net Book Value
As at 31 October 2023 252
As at 1 November 2022 192
5. Share Capital
2023 2022
Allotted, called up and fully paid £ £
100 Ordinary Shares of £ 1 each 100 100
6. Controlling Party
The company's controlling party is Christopher Dott by virtue of his ownership of 60% of the issued share capital in the company.
Page 4